SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Enovis Corp. – ‘10-K’ for 12/31/22 – ‘EX-10.64’

On:  Wednesday, 3/1/23, at 11:17am ET   ·   For:  12/31/22   ·   Accession #:  1420800-23-8   ·   File #:  1-34045

Previous ‘10-K’:  ‘10-K’ on 2/22/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 2/22/24 for 12/31/23   ·   26 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/01/23  Enovis Corp.                      10-K       12/31/22  124:18M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.85M 
 2: EX-10.36    Material Contract                                   HTML     42K 
 3: EX-10.38    Material Contract                                   HTML     39K 
 4: EX-10.63    Material Contract                                   HTML     51K 
 5: EX-10.64    Material Contract                                   HTML     48K 
 6: EX-21.1     Subsidiaries List                                   HTML     51K 
 7: EX-23.1     Consent of Expert or Counsel                        HTML     31K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     37K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     32K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     32K 
17: R1          Cover Page                                          HTML     93K 
18: R2          Audit Information                                   HTML     35K 
19: R3          Consolidated Statements of Income                   HTML    156K 
20: R4          Consolidated Statements of Comprehensive Income     HTML     74K 
                (Loss)                                                           
21: R5          CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)     HTML     41K 
                INCOME [Parenthetical]                                           
22: R6          Consolidated Balance Sheets                         HTML    158K 
23: R7          Consolidated Balance Sheets [Parenthetical]         HTML     42K 
24: R8          Consolidated Statements of Equity                   HTML    101K 
25: R9          Consolidated Statements of Equity [Parenthetical]   HTML     33K 
26: R10         Consolidated Statements of Cash Flows               HTML    136K 
27: R11         Organization and Nature of Operations               HTML     39K 
28: R12         Summary of Significant Accounting Policies          HTML     71K 
                Accounting Policies                                              
29: R13         Recently Issued Accounting Pronouncements           HTML     32K 
30: R14         Discontinued Operations                             HTML     87K 
31: R15         Acquisitions                                        HTML     58K 
32: R16         Revenue                                             HTML     63K 
33: R17         Net Income Per Share                                HTML     57K 
34: R18         Income Taxes                                        HTML    122K 
35: R19         Goodwill and Intangible Assets                      HTML     72K 
36: R20         Property, Plant and Equipment, Net                  HTML     45K 
37: R21         Inventories, Net                                    HTML     40K 
38: R22         Leases                                              HTML     41K 
39: R23         Debt                                                HTML     64K 
40: R24         Equity                                              HTML    191K 
41: R25         Accrued Liabilities                                 HTML     93K 
42: R26         Defined Benefit Plans Defined Benefit Plans         HTML    352K 
43: R27         Financial Instruments and Fair Value Measurements   HTML    102K 
44: R28         Commitments and Contingencies                       HTML     35K 
45: R29         Segment Information                                 HTML    123K 
46: R30         Selected Quarterly Data - (Unaudited)               HTML    104K 
47: R31         Schedule Ii - Valuation and Qualifying Accounts     HTML     57K 
48: R32         Summary of Significant Accounting Policies          HTML    118K 
                Accounting Policies (Policies)                                   
49: R33         Discontinued Operations (Tables)                    HTML     82K 
50: R34         Acquisitions (Tables)                               HTML     48K 
51: R35         Revenue (Tables)                                    HTML     59K 
52: R36         Net Income Per Share (Tables)                       HTML     53K 
53: R37         Income Taxes (Tables)                               HTML    120K 
54: R38         Goodwill and Intangible Assets (Tables)             HTML     75K 
55: R39         Property, Plant and Equipment, Net (Tables)         HTML     44K 
56: R40         Inventories, Net (Tables)                           HTML     41K 
57: R41         Leases (Tables)                                     HTML     40K 
58: R42         Debt (Tables)                                       HTML     51K 
59: R43         Equity (Tables)                                     HTML    183K 
60: R44         Accrued Liabilities (Tables)                        HTML     95K 
61: R45         Defined Benefit Plans Defined Benefit Plans         HTML    356K 
                (Tables)                                                         
62: R46         Financial Instruments and Fair Value Measurements   HTML     93K 
                (Tables)                                                         
63: R47         Segment Information (Tables)                        HTML    122K 
64: R48         Selected Quarterly Data - (Unaudited) (Tables)      HTML    104K 
65: R49         Organization and Nature of Operations (Details)     HTML     98K 
66: R50         Summary of Significant Accounting Policies          HTML     34K 
                Accounting Policies - Investments (Details)                      
67: R51         Summary of Significant Accounting Policies          HTML     73K 
                Accounting Policies- Additional (Details)                        
68: R52         Discontinued Operations - Narrative (Details)       HTML     72K 
69: R53         Discontinued Operations - Carrying Value of Assets  HTML     97K 
                and Liabilities (Details)                                        
70: R54         Discontinued Operations - Financial Results of the  HTML     85K 
                Fabrication Business (Details)                                   
71: R55         Acquisitions - Narrative (Details )                 HTML    135K 
72: R56         Acquisitions and Investments - Assets Acquired and  HTML     53K 
                Liabilities Assumed (Details)                                    
73: R57         Acquisitions - Summary of Intangible Assets         HTML     42K 
                Acquired (Details)                                               
74: R58         Revenue - Disaggregation of Revenue (Details)       HTML     64K 
75: R59         Revenue - Allowance for Credit Losses (Details)     HTML     41K 
76: R60         Net Income Per Share (Details)                      HTML     59K 
77: R61         Net Income Per Share - Narrative (Details)          HTML     55K 
78: R62         Income Taxes - Domestic and Foreign (Details)       HTML     68K 
79: R63         Income Taxes - Reconciliation (Details)             HTML     61K 
80: R64         Income Taxes - Deferred Tax Assets and Liabilities  HTML     59K 
                (Details)                                                        
81: R65         Income Taxes - Narrative (Details)                  HTML     72K 
82: R66         Income Taxes - Gross Unrecognized Tax Benefits      HTML     48K 
                (Details)                                                        
83: R67         Goodwill and Intangible Assets - Goodwill           HTML     44K 
                (Details)                                                        
84: R68         Goodwill and Intangible Assets - Intangible Assets  HTML     49K 
                (Details)                                                        
85: R69         Goodwill and Intangible Assets - Amortization       HTML     35K 
                Expense Narrative (Details)                                      
86: R70         Goodwill and Intangible Assets - Annual             HTML     41K 
                Amortization Expense (Details)                                   
87: R71         Property, Plant and Equipment, Net (Details)        HTML     53K 
88: R72         Property, Plant and Equipment, Net - Narrative      HTML     34K 
                (Details)                                                        
89: R73         Inventories, Net (Details)                          HTML     43K 
90: R74         Leases (Details)                                    HTML     62K 
91: R75         Leases - Narrative (Details)                        HTML     32K 
92: R76         Debt -Components (Details)                          HTML     49K 
93: R77         Debt - Narrative (Details)                          HTML    148K 
94: R78         Debt (Schedule of Debt Maturities) (Details)        HTML     56K 
95: R79         Equity - Narrative (Details)                        HTML     93K 
96: R80         Equity - Changes in Accumulated Other               HTML     78K 
                Comprehensive Income (Details)                                   
97: R81         Equity - Stock-based compensation (Details)         HTML     37K 
98: R82         Equity - Option Valuation Assumptions (Details)     HTML     45K 
99: R83         Equity - Option Award Activity (Details)            HTML     92K 
100: R84         Equity - PRSU and RSU Activity (Details)            HTML     71K  
101: R85         Equity - Tangible Equity Units (Details)            HTML     54K  
102: R86         Accrued Liabilities - Schedule of Accrued           HTML     69K  
                Liabilities (Details)                                            
103: R87         Accrued Liabilities - Restructuring (Details)       HTML     67K  
104: R88         Defined Benefit Plans -Narrative (Details)          HTML     74K  
105: R89         Defined Benefit Plans - Plans Obligation and Asset  HTML    138K  
                Rollforward (Details)                                            
106: R90         Defined Benefit Plans - Defined Benefit Expected    HTML     44K  
                Benefit Payments (Details)                                       
107: R91         Defined Benefit Plans - Plan Asset Allocation       HTML     62K  
                (Details)                                                        
108: R92         Defined Benefit Plans - Plan Asset Allocation,      HTML    103K  
                Fair Value Hierarchy (Details)                                   
109: R93         Defined Benefit Plans Net Periodic Benefit Cost     HTML     85K  
                (Details)                                                        
110: R94         Defined Benefit Plans Defined Benefit Plan,         HTML     43K  
                Accumulated Other Comprehensive Income (Details)                 
111: R95         Defined Benefit Plans Key Economic Assumptions      HTML     51K  
                (Details)                                                        
112: R96         Financial Instruments and Fair Value Measurements   HTML     54K  
                - Narrative (Details )                                           
113: R97         Financial Instruments and Fair Value Measurements   HTML     61K  
                Fair Value Hierarchy (Details)                                   
114: R98         Financial Instruments and Fair Value Measurements   HTML     44K  
                Gain (Loss) on Derivative Instruments (Details)                  
115: R99         Commitments and Contingencies - Narrative (Details  HTML     32K  
                )                                                                
116: R100        Segment Information - Results and Reconciliation    HTML    109K  
                of Operating Loss to Adjusted EBITDA (Details)                   
117: R101        Segment Information Net Sales and PPE by Geography  HTML     62K  
                (Details)                                                        
118: R102        Selected Quarterly Data - (Unaudited) (Details)     HTML    122K  
119: R103        Schedule Ii - Valuation and Qualifying Accounts     HTML     51K  
                (Details)                                                        
122: XML         IDEA XML File -- Filing Summary                      XML    222K  
120: XML         XBRL Instance -- cfx-20221231_htm                    XML   5.05M  
121: EXCEL       IDEA Workbook of Financial Reports                  XLSX    273K  
13: EX-101.CAL  XBRL Calculations -- cfx-20221231_cal                XML    368K 
14: EX-101.DEF  XBRL Definitions -- cfx-20221231_def                 XML   1.14M 
15: EX-101.LAB  XBRL Labels -- cfx-20221231_lab                      XML   2.83M 
16: EX-101.PRE  XBRL Presentations -- cfx-20221231_pre               XML   1.78M 
12: EX-101.SCH  XBRL Schema -- cfx-20221231                          XSD    257K 
123: JSON        XBRL Instance as JSON Data -- MetaLinks              714±  1.13M  
124: ZIP         XBRL Zipped Folder -- 0001420800-23-000008-xbrl      Zip    962K  


‘EX-10.64’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

image_0a.jpg


December 14, 2018


Ms. Patty Lang Via Email


Strictly private and confidential

Dear Patty,
Congratulations! We are very pleased to extend you an employment offer for the position of Chief Human Resource Officer and Senior Vice President, Colfax Corporation, reporting to Matthew Trerotola, President and CEO, Colfax Corporation. This offer has been approved by the Board of Directors and is valid until December 31st, 2018.

We look forward to having you as a part of our team, adding your skills, experiences and talent to our group. We believe Colfax is the type of organization that has the vision, culture and opportunities to further your career success and a tremendous opportunity to build long-term wealth in the growth and profitability of Colfax.

Date of Employment    We anticipate that you will begin employment by 21 January 2019.

Base Salary    Your starting annual salary will be US $440,000 payable bi-weekly. You will be eligible for an annual merit increase based on benchmark and company merit increase guidelines, effective April 1, 2020.

Annual Cash Bonus    You will be eligible to participate in our Management Incentive Compensation Plan (MIP) with a target of 65% of your base salary. The actual MIP payout is based on the achievement of Colfax financial performance against pre-set threshold, target, and maximum and your individual performance factor of up to 1.5 times the financial factor. The maximum payout is 250% of target. Your 2019 MIP award will be pro-rated for a partial year of employment based on your start date.

Equity Awards    You will be provided a new hire equity award of $650,000. The effective grant date will be in February at the same time as the Colfax annual grant process occurs.
The grant will follow the 2019 approved allocation and vesting for executive officers: 50% in stock options to be vested 33% on the 1st – 3rd anniversaries of grant and 50% in performance-based restricted stock units with 100% vesting on the 3rd anniversary of grant if earned. If the threshold performance is achieved in the performance period, you are eligible to vest in 50% of the units according to the vesting schedule. If the threshold performance is not met within the performance period, all the units will be forfeited.
Performance over threshold will result in vesting units against a linear payout formula up to 200% of the target number of units with a limit of 400% total value as compared to target value. The 400% cap is determined by the number of units earned times the stock

image_1.jpgColfax Corporation
2711 Centerville Road Suite 400
Wilmington, DE 19808 colfaxcorp.com


Patty Lang Offer Letter – Page 2 of 4



price at vesting divided by the original value of the grant. There is a one-year hold on sale of 50% of the net after tax shares delivered at vesting.

The strike price of the stock options will be determined by the Fair Market Value of Colfax Corporation common stock on the effective date of the grant after you start with Colfax. Options are valued based on Black Scholes model for your grant date prepared by management. Specific numbers of performance-based restricted stock will be determined based on the accounting valuation at the time of grant.

In addition, you will be eligible for future annual equity grants starting in 2020 based on your position and performance in accordance with our equity guidelines. The current target for your position is $650,000. Annual equity awards are currently delivered in 50% stock options and 50% performance-based restricted stock units.

The terms and conditions of equity awards will be in accordance with the Colfax's 2016 Omnibus Incentive Plan or successor plan. You will receive a copy of our equity brochure including illustration.

401(k)    You will have the opportunity to participate in the Colfax 401(k) Savings Plan Plus with matching contributions. Colfax matches 100% of the first 4% that you contribute, and these matching contributions vest immediately. In addition, at its discretion, Colfax will make non-elective contributions of 2% into your account. These non-elective contributions vest over five years

NQ Deferred Comp    You will have the opportunity to defer up to 50% of base salary and 75% bonus in the nonqualified deferred compensation and optimize the company matching contribution above the IRS thresholds in 401(k). Colfax matches 100% of the first 4% that you contribute, and these matching contributions vest immediately. In addition, at its discretion, Colfax will make non-elective contributions of 2% into your account as long as you contribute at least 1% of base salary. These non-elective contributions vest over five years

Transition Bonus    You will receive a transition bonus of US $400,000. If you resign from the company within the first two years of employment, you are required to reimburse a prorated share of this amount based on number of months employed as a percent of 24 months.

Relocation    You will be eligible for Colfax’s relocation managed by our relocation vendor Lexicon. You have two years from your hire date to complete your relocation, unless an exception is approved. You will receive 3 months of temporary living and household goods storage in addition to selling services. Part of your relocation is taxable and part of it is non-taxable in accordance with IRS guidelines. Colfax does not provide gross-ups other than for customary relocation expenses such as temporary living and movement of household goods per policy disclosed in the proxy. Your gross-ups will be done at your effective tax rate versus the standard 22%. Officers of the company may not receive loans.

Colfax Corporation
2711 Centerville Road Suite 400
Wilmington, DE 19808 colfaxcorp.com

Patty Lang Offer Letter – Page 3 of 4




Additionally, if you resign from the company within the first 2 years of employment, you are required to reimburse the company for amounts paid on your behalf at a rate of 100% of the total costs paid by the company within one year and 50% of total costs after that up to the end of year two. Please see our relocation guide for more information on the program.

Health Benefits    You and your family will be eligible to participate in the health & welfare benefits including medical, dental, vision, short term and long term disability, life and accidental death and dismemberment insurance. The benefits start on the 1st of the month following your start date.

Perquisites    You will be eligible for a reimbursement of up to $10,000 annually for financial planning and tax preparation expenses on your behalf.

Vacation & Holidays    You will be eligible for four weeks of vacation, plus three floating holidays and any company-paid holidays.

Severance    You are eligible for the current Colfax Executive Officer Severance Plan (the “Severance Plan”). However, notwithstanding any provision to the contrary in the Severance Plan, in the event your employment is terminated involuntarily, not for cause, you will instead receive one times your current base salary and one times your target annual bonus. In the event your employment is terminated within three months before or two years after a Change in Control, you will instead receive an amount equal to the severance plan benefit plus an amount equal to your current base salary and your target annual bonus. For purposes of this Agreement, a “Change in Control” means any of the following: (a) a takeover bid (within the meaning of the Securities Act); (b) any consolidation, merger or amalgamation of the Company with or into any other corporation whereby the voting shareholders of the Company immediately prior to such event receive less than 50% of the voting shares of the surviving corporation; (c) a sale by the Company of all or substantially all of the Company’s undertakings or assets; (d) a proposal by or with respect to the Company being made in connection with a liquidation, dissolution or winding up of the Company; (e) any reorganization, reverse stock split, transaction, or recapitalization of the Company that would result in a Change of Control as otherwise defined herein.

Colfax Corporation
2711 Centerville Road Suite 400
Wilmington, DE 19808 colfaxcorp.com

Patty Lang Offer Letter – Page 4 of 4









Patty, we also want to confirm that your employment is “at will”. This means that your employment is for no definite period of time, and either you or the company may terminate your employment at any time, with or without cause or notice. In accordance with Colfax policy, this offer is contingent upon acceptance of the confidentiality agreement and code of conduct. You agree that during your employment, and for two years after termination of your employment, you will not directly or indirectly, for yourself or on behalf of any other person, partnership, company, corporation, or other entity, solicit, induce, recruit, encourage, or otherwise endeavor to cause or attempt to cause any employee or consultant of Colfax, or any independent contractor providing services to Colfax, to terminate his or her relationship with Colfax. You agree that the harm caused to Colfax by violation of this provision would amount to irreparable harm justifying entry of a temporary restraining order and/or a preliminary injunction and an award of attorney fees to Colfax.

We look forward to having you join us. It will be an excellent opportunity to work together to take the business to the next level of growth and success!



Sincerely,    ACKNOWLEGED & ACCEPTED:


Matthew L. Trerotola                /s/ Patty Lang            12/17/2018
President and Chief Executive Officer    Patty Lang    Date Colfax Corporation
Colfax Corporation
2711 Centerville Road Suite 400
Wilmington, DE 19808 colfaxcorp.com

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/1/23
For Period end:12/31/225,  8-K
4/1/20
12/14/18
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/24  Enovis Corp.                      10-K       12/31/23  123:15M
 6/01/23  Enovis Corp.                      S-8         6/01/23    4:91K                                    Donnelley … Solutions/FA


24 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/13/22  Enovis Corp.                      8-K:5,9     6/07/22   11:173K                                   Donnelley … Solutions/FA
 4/08/22  Enovis Corp.                      8-K:1,2,3,5 4/04/22   22:3.1M                                   Donnelley … Solutions/FA
 2/22/22  Enovis Corp.                      10-K       12/31/21  129:18M
 3/05/21  Enovis Corp.                      8-K:5,9     3/03/21   18:468K                                   Donnelley … Solutions/FA
 2/18/21  Enovis Corp.                      10-K       12/31/20  129:19M
10/29/20  Enovis Corp.                      10-Q       10/02/20   81:8M
 5/27/20  Enovis Corp.                      8-K:5,9     5/20/20   20:1M                                     Quality EDGAR So… LLC/FA
 4/09/20  Enovis Corp.                      8-K:5,9     4/03/20   12:260K                                   Donnelley … Solutions/FA
 2/24/20  Enovis Corp.                      10-K       12/31/19  136:22M
 5/17/19  Enovis Corp.                      8-K:1,7,9   5/15/19    3:721K                                   Donnelley … Solutions/FA
 2/21/19  Enovis Corp.                      10-K       12/31/18  126:18M
 2/16/18  Enovis Corp.                      10-K       12/31/17  114:17M
 9/25/17  Enovis Corp.                      8-K:1,7,9   9/24/17    3:2.4M                                   Broadridge Fin’l… Inc/FA
 2/14/17  Enovis Corp.                      10-K       12/31/16  116:15M
 7/28/16  Enovis Corp.                      10-Q        7/01/16   71:6.8M
 2/16/16  Enovis Corp.                      10-K       12/31/15  116:17M
 7/23/15  Enovis Corp.                      10-Q        6/26/15   72:7M
 7/23/15  Enovis Corp.                      8-K:5,9     7/23/15    4:237K                                   Donnelley … Solutions/FA
 2/19/13  Enovis Corp.                      10-K       12/31/12  124:12M                                    Toppan Merrill/FA
 8/07/12  Enovis Corp.                      10-Q        6/29/12   99:7.8M                                   Toppan Merrill/FA
 1/30/12  Enovis Corp.                      8-K:1,3,9   1/24/12    7:1M                                     Skadden/FA
 5/01/08  Enovis Corp.                      S-1/A¶                18:3.5M                                   Donnelley … Solutions/FA
 4/23/08  Enovis Corp.                      S-1/A¶                 9:2.8M                                   Donnelley … Solutions/FA
 3/11/08  Enovis Corp.                      S-1/A¶                15:3.3M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001420800-23-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 5:19:21.4am ET